Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
Radioimmunotherapy for B-cell non-Hodgkin lymphoma
Thomas E. Witzig
Hematology
Research output
:
Contribution to journal
›
Review article
›
peer-review
30
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Radioimmunotherapy for B-cell non-Hodgkin lymphoma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
B-Cell Lymphoma
74%
CD20 Antigens
22%
Drug Therapy
8%
ibritumomab tiuxetan
47%
Immunoconjugates
19%
iodine-131 anti-B1 antibody
25%
Maintenance
10%
Monoclonal Antibodies
10%
Neoplasms
4%
Non-Hodgkin's Lymphoma
68%
Outpatients
10%
Radiation Tolerance
16%
Radioimmunotherapy
100%
Rituximab
31%
Stem Cells
10%
Therapeutics
4%
Chemical Compounds
Adjuvant
89%
Dose
55%
Refractory
74%